Dupuytren's Contracture and Lederhose Disease

Radiation therapy is an effective option for non-cancerous conditions including Dupuytren’s contracture and Ledderhose’s disease.

Ackerman Cancer Center uses advanced radiation therapy technologies to treat Dupuytren’s contracture and Ledderhose’s disease, softening the tissue and relieving the symptoms.

Treatments

A variety of treatment options are available for Dupuytren’s contracture including surgery, needle aponeurotomy, collagen injection, steroid injections, cryosurgery, and radiation therapy.

Ackerman Cancer Center offers radiation therapy as a non-surgical treatment option. To treat Dupuytren’s, radiation is delivered directly to the diseased tissue daily for five days in a row, followed by a treatment-free period ranging from six to 12 weeks. Finally, an additional series of five treatments is administered.

The radiation works to soften the affected tissue and restore function. It also helps prevent future contraction of the cords or nodules from forming. Treatment is most effective in the early stages of the disease, but may also be beneficial in later disease.

The board-certified radiation oncologists at Ackerman Cancer Center work closely with each patient to develop a radiation treatment plan designed to produce optimal results for patients with Dupuytren’s and Ledderhose.

What to Expect

For more information about the non-cancerous conditions treated at Ackerman Cancer Center, please contact us at 904-880-5522, or click here to learn what to expect during your treatment. 

Visit our wellness calendar to find out about upcoming support programs at Ackerman Cancer Center.

Reviews

Read the latest review on Healthgrades.

Reviews

Blog

If you have ever researched a new diet or meal plan, chances are it suggested almonds as a healthy snack alternative. Karen explains why they are so good for you in our blog!

Blog

In The News

Dr. Ackerman was on WJXT talking about the dangers of delaying screening during COVID.

In The News

Facebook

Like us on Facebook for all the newest info from our cutting-edge cancer center.

Facebook